
|Articles|January 1, 2003
Accutane Illicitly Sold, Congress, FDA Warn
Author(s)Thomas P. Skernivitz
Washington - Tighter restrictions on Accutane could have a reverse effect - increased black market activity - the FDA told a congressional investigative subcommittee on Dec. 11.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
3
Journal Digest: January 14, 2026
4
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
5


















